William D. Welch

650 total citations
33 papers, 522 citations indexed

About

William D. Welch is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, William D. Welch has authored 33 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in William D. Welch's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). William D. Welch is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). William D. Welch collaborates with scholars based in United States. William D. Welch's co-authors include Lauri Thrupp, Paul Stevens, Lowell S. Young, Ronald D. Miller, June Zaccari, Paul Southern, Gary A. Cartwright, Gary D. Becker, Jordan Weiss and Roger E. Bawdon and has published in prestigious journals such as The Journal of Immunology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

William D. Welch

33 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William D. Welch United States 13 127 112 82 71 69 33 522
Gunnar Briheim Sweden 11 185 1.5× 235 2.1× 35 0.4× 62 0.9× 36 0.5× 18 648
David Elphick United Kingdom 11 95 0.7× 69 0.6× 56 0.7× 94 1.3× 83 1.2× 20 523
Daisuke Hata Japan 14 195 1.5× 83 0.7× 53 0.6× 79 1.1× 145 2.1× 50 662
Min Gi Ban South Korea 8 370 2.9× 55 0.5× 74 0.9× 43 0.6× 50 0.7× 13 629
Zhitao Li China 13 136 1.1× 49 0.4× 38 0.5× 62 0.9× 71 1.0× 47 585
Russell E.N. Becker United States 12 114 0.9× 70 0.6× 32 0.4× 49 0.7× 55 0.8× 26 469
E. M. Schneider Germany 13 141 1.1× 355 3.2× 39 0.5× 180 2.5× 62 0.9× 23 792
I. Nuzzo Italy 11 95 0.7× 102 0.9× 27 0.3× 81 1.1× 13 0.2× 27 346
Roelof van Dalen Netherlands 8 32 0.3× 91 0.8× 44 0.5× 121 1.7× 34 0.5× 13 385
Fiona Johnston United Kingdom 11 145 1.1× 127 1.1× 16 0.2× 188 2.6× 53 0.8× 22 773

Countries citing papers authored by William D. Welch

Since Specialization
Citations

This map shows the geographic impact of William D. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Welch more than expected).

Fields of papers citing papers by William D. Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William D. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Welch. The network helps show where William D. Welch may publish in the future.

Co-authorship network of co-authors of William D. Welch

This figure shows the co-authorship network connecting the top 25 collaborators of William D. Welch. A scholar is included among the top collaborators of William D. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William D. Welch. William D. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherman, Stuart, Waleed Alazmi, Glen A. Lehman, et al.. (2009). Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis. Gastrointestinal Endoscopy. 69(3). 462–472. 13 indexed citations
2.
3.
Becker, Gary D. & William D. Welch. (1990). Quantitative bacteriology of closed‐suction wound drainage in contaminated surgery. The Laryngoscope. 100(4). 403–406. 11 indexed citations
4.
Becker, Gary D. & William D. Welch. (1990). Quantitative bacteriology of intraoperative wound tissue in contaminated surgery. Head & Neck. 12(4). 293–297. 4 indexed citations
5.
Welch, William D. & Roger E. Bawdon. (1986). Cefotaxime metabolism by hemolyzed blood:. Diagnostic Microbiology and Infectious Disease. 4(2). 119–124. 9 indexed citations
6.
Welch, William D.. (1985). Enflurane and Isoflurane Inhibit the Oxidative Activity of Pulmonary Alveolar Macrophages. Respiration. 47(1). 24–29. 6 indexed citations
7.
Welch, William D. & Paul Southern. (1984). Unusual susceptibility of methicillin-resistant Staphylococcus aureus to erythromycin, clindamycin, gentamicin, and tetracycline at 30 degrees C but not at 35 degrees C. Journal of Clinical Microbiology. 19(6). 831–833. 8 indexed citations
8.
Welch, William D. & Ronald D. Miller. (1984). Effect of Enflurane, Isoflurane, and Nitrous Oxide on the Microbicidal Activity of Human Polymorphonuclear Leukocytes. Anesthesiology. 61(2). 188–192. 35 indexed citations
9.
Bawdon, Roger E., William J. Novick, David L. Hemsell, & William D. Welch. (1984). High-Pressure Liquid Chrohatographic Assay of Cefotaxime and Desacetylcefotaxime in Human Myometrium. Journal of Liquid Chromatography. 7(12). 2483–2491. 2 indexed citations
10.
Welch, William D., et al.. (1984). Evaluation of the MS-2® and Lumac® Systems for the Rapid Screening of Urine Specimens. American Journal of Clinical Pathology. 81(5). 629–633. 7 indexed citations
11.
Welch, William D.. (1983). Halothane Inhibits the Microbicidal Oxidative Activity of Pulmonary Alveolar Macrophages. Anesthesiology. 58(5). 456–459. 13 indexed citations
12.
Welch, William D., et al.. (1983). Minimal inhibitory concentrations of 19 antimicrobial agents for 96 clinical isolates of group IVe bacteria. Antimicrobial Agents and Chemotherapy. 24(3). 432–433. 4 indexed citations
13.
Welch, William D. & Pauline Devlin. (1983). Hydrocortisone sodium succinate reversibly inhibits human neutrophil oxidative activity at clinically relevant concentrations. Chemico-Biological Interactions. 43(2). 239–244. 9 indexed citations
14.
Welch, William D., David M. Rose, & Robert Carlson. (1982). Reduced hemoglobin as an inhibitor of human polymorphonuclear leukocyte bacterial killing. Role of hemoglobin--oxygen tension in polymorphonuclear function.. PubMed. 91(1). 75–80. 6 indexed citations
15.
Cullen, Bruce F., et al.. (1982). Antacid Aspiration in Rabbits. Anesthesia & Analgesia. 61(3). 288???292–288???292. 16 indexed citations
16.
Graham, Charles W., June Zaccari, & William D. Welch. (1981). Halothane inhibits human neutrophil chemi luminescence. Clinical research. 29(2). 352. 1 indexed citations
17.
Welch, William D., et al.. (1981). Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function. Antimicrobial Agents and Chemotherapy. 20(1). 15–20. 59 indexed citations
18.
Welch, William D.. (1980). Correlation between measurements of the luminol-dependent chemiluminescence response and bacterial susceptibility to phagocytosis. Infection and Immunity. 30(2). 370–374. 59 indexed citations
19.
Graham, Charles W., William D. Welch, & June Zaccari. (1979). A POSSIBLE MECHANISM FOR ANESTHETIC DEPRESSION OF LUNG MACROPHAGES. Anesthesiology. 51(3). S49–S49. 2 indexed citations
20.
Welch, William D., William Martin, Paul Stevens, & Lowell S. Young. (1979). Relative Opsonic and Protective Activities of Antibodies against K1, O and Lipid A Antigens of Escherichia Coli. Scandinavian Journal of Infectious Diseases. 11(4). 291–301. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunnar Briheim Breakdown of academic impact, for papers by David Elphick Breakdown of academic impact, for papers by Daisuke Hata Breakdown of academic impact, for papers by Min Gi Ban Breakdown of academic impact, for papers by Zhitao Li Breakdown of academic impact, for papers by Russell E.N. Becker Breakdown of academic impact, for papers by E. M. Schneider Breakdown of academic impact, for papers by I. Nuzzo Breakdown of academic impact, for papers by Roelof van Dalen Breakdown of academic impact, for papers by Fiona Johnston
Rankless by CCL
2026